Photo taken from ESTRO/X
Jul 6, 2024, 11:24
Insights from ESTRO24 on reirradiation in NSCLC by Jonas Willmann
European Society for Radiotherapy and Oncology shared on X:
“Insights from ESTRO24 on reirradiation in NSCLC and its impact on overall survival rates. Report on 2 studies, focusing on:
- optimal re-irradiation doses in NSCLC
- high-dose re-irradiation for lung cancer recurrences.“
Read further.
Source: European Society for Radiotherapy and Oncology/X